Oligomenorrhea. Secondary Oligomenorrhoea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The desire to participate in the study Conscientiousness Women aged 20-40 Oligomenorrhea: Delayedness from 40 days to 3 months Not having adrenal problems, thyroid and prolactin, cardiovascular diseases, diabetes, chronic diseases of the liver Non-pregnancy (negative pregnancy test) Non-lactation Not having known known uterus, ovaries and ... Not using concurrent hormonal treatments (chemical or herbal) BMI more than 18.5 kg / m²
Exclusion criteria
Exclusion criteria: Unwilling to continue participating in the study The diseases that Oraz continues to block the study Any abnormal anatomical condition or women's cancers Pregnancy and breastfeeding Receiving any hormonal medication (chemical or herbal) within the last 2 months Severe drug allergy or a history of unusual reactions to herbal medicines Need for other interventions Skinny people (BMI less than 18.5 kg / m²)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menstrual start. Timepoint: Before the intervention, on the 1st, 2nd, and 3rd months, proceeded to work. Method of measurement: Question from the patient.;Bleeding time. Timepoint: Before the intervention, on the 1st, 2nd, and 3rd months, proceeded to. Method of measurement: Question from the patient.;The duration of each bleeding. Timepoint: Before the intervention, on the 1st, 2nd, and 3rd months, proceeded to. Method of measurement: Question from the patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: During the study. Method of measurement: question. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences